We are investigating Express Scripts Holding Co. Acquisition (“Express Scripts” or the “Company”) (NasdaqGS: ESRX) relating to the sale of the Company to Cigna Corporation. (“Cigna”). Under the terms of the agreement, the Company’s shareholders will receive $48.75 in cash and 0.2434 of a share of the newly combined company for each Express Scripts share they own, representing consideration of $96.03 per share